Figures computed from official regulatory filings — .
Statistical track record
Free accountWin rates, median returns and the proven-insider analysis come with a free account.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
INNATE PHARMAListing unverified | Award | $3.5M | AMF | ||
ORANGEListing unverified | Sell | $1.3B | Unusual size | AMF | |
ARVERNE GROUP S.A.Listing unverified | Buy | $163.8K | conv 6 | AMF | |
ARVERNE GROUP S.A.Listing unverified | Award | $22.7M | AMF | ||
ARVERNE GROUP S.A.Listing unverified | Buy | $203.4K | conv 6 | AMF | |
ARVERNE GROUP S.A.Listing unverified | Buy | $53.8K | conv 6 | AMF | |
DIAGNOSTIC MEDICAL SYSTEMSListing unverified | Sell | $2.3M | AMF | ||
VERALLIAListing unverified | Other | $5.3M | AMF | ||
VERALLIAListing unverified | Exercise | $5.3M | AMF | ||
ESSILORLUXOTTICAListing unverified | Buy | $57.1M | conv 66ClusterUnusual size | AMF | |
TERACTListing unverified | Other | $4.4M | AMF | ||
WORLDLINEListing unverified | Award | $3.7M | AMF | ||
WORLDLINEListing unverified | Award | $43.5M | AMF | ||
WORLDLINEListing unverified | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | AMF | ||
WORLDLINEListing unverified | Award | $53.2M | Unusual size | AMF | |
DBV TECHNOLOGIESListing unverified | Sell | $306.7K | AMF | ||
DBV TECHNOLOGIESListing unverified | Sell | $413.1K | AMF | ||
DBV TECHNOLOGIESListing unverified | Sell | $3.3M | AMF | ||
DBV TECHNOLOGIESListing unverified | Sell | $1M | AMF | ||
DBV TECHNOLOGIESListing unverified | Sell | $434K | AMF | ||
DBV TECHNOLOGIESListing unverified | Sell | $724.9K | AMF | ||
DBV TECHNOLOGIESListing unverified | Sell | $5.4M | AMF | ||
DBV TECHNOLOGIESListing unverified | Sell | $3.5M | AMF | ||
DBV TECHNOLOGIESListing unverified | Sell | $2.8M | AMF | ||
DBV TECHNOLOGIESListing unverified | Sell | $378.4K | AMF |